Abstract
Modern burn care has led to unprecedented survival rates in burn patients whose injuries were fatal a few decades ago. Along with improved survival, new challenges have emerged in the management of burn patients. Infections top the list of the most common complication after burns, and sepsis is the leading cause of death in both adult and pediatric burn patients. The diagnosis and management of sepsis in burns is complex as a tremendous hypermetabolic response secondary to burn injury can be superimposed on systemic infection, leading to organ dysfunction. The management of a septic burn patient represents a challenging scenario that is commonly encountered by providers caring for burn patients despite preventive efforts. Here, we discuss the current perspectives in the diagnosis and treatment of sepsis and septic shock in burn patients.
Original language | English (US) |
---|---|
Pages (from-to) | 1107-1117 |
Number of pages | 11 |
Journal | Therapeutics and Clinical Risk Management |
Volume | 13 |
DOIs | |
State | Published - Aug 29 2017 |
Keywords
- Antibiotics
- Biomarkers
- Burn injury
- Burn sepsis
- Cytokines
- Procalcitonin
- Thermal injury
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)
- Chemical Health and Safety
- Safety Research